It is a chemicals and materials private limited company based in Ambarnath, Maharashtra, India, established in 2017.
2017 | Ambarnath, Maharashtra, India | ActiveD.K. Pharma Tech Private Limited, a active private limited company, was established on 23 March 2017 in Ambarnath, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24100MH2017PTC292880. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Rakesh Kasturilal Bakshi (Director), Karan Rakesh Bakshi (Director), Ravindra Omprakash Sharma (Director). Past directors included Rakesh Kasturilal Bakshi, Ajay Jagdish Saboo, Karan Rakesh Bakshi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shed No. Ts-30,Plot No.26 & 46,, Midc Badlapur, Ambarnath, Maharashtra, 421503.
U24100MH2017PTC292880
292880
23 March 2017
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into D.K. Pharma Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Kasturilal Bakshi | Director | 25 Mar 2019 | Current |
| Karan Rakesh Bakshi | Director | 05 Aug 2024 | Current |
| Ravindra Omprakash Sharma | Director | 05 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Nominee Director | 28 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Nominee Director | 25 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kajay Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.87% increase. The company also saw a substantial improvement in profitability, with a 930.56% increase in profit. The company's net worth Soared by an impressive increase of 39.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, D.K. Pharma Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with D.K. Pharma Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of D.K. Pharma Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D.K. Pharma Tech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity D.K. Pharma Tech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Karan Rakesh Bakshi was appointed as a Director was appointed as a Director on 05 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
Progress on Ravindra Omprakash Sharma was appointed as a Director was appointed as a Director on 05 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
D.K. Pharma Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Rakesh Kasturilal Bakshi was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 8 months . was documented.
D.K. Pharma Tech Private Limited was registered on 23 Mar 2017 with Roc Mumbai & aged 8 years 8 months as per MCA records. was recorded as a recent event.
The CIN of D.K. Pharma Tech Private Limited is U24100MH2017PTC292880.
D.K. Pharma Tech Private Limited is headquartered at Shed No. Ts-30,Plot No.26 & 46,, Midc Badlapur, Ambarnath, Maharashtra, 421503.
D.K. Pharma Tech Private Limited was incorporated on 23 March 2017.
The current directors of D.K. Pharma Tech Private Limited are
The primary industry of D.K. Pharma Tech Private Limited is Manufacturing.
D.K. Pharma Tech Private Limited is unlisted.
The authorized capital of D.K. Pharma Tech Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of D.K. Pharma Tech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX